Particle.news

Download on the App Store

ADHD Medication Zenzedi Recalled Due to Pill Mix-Up

Patients Risk Undertreatment of Symptoms and Increased Accidents Due to Sedative Found in Bottles

  • Azurity Pharmaceuticals is recalling one lot of its ADHD and narcolepsy medication, Zenzedi, after a pharmacist found an antihistamine drug, Carbinoxamine Maleate, in a bottle labeled as Zenzedi.
  • The two medications have opposite effects: Zenzedi is a stimulant used for the treatment of ADHD and narcolepsy, while Carbinoxamine Maleate is a sedative used to treat allergies.
  • Patients who take Carbinoxamine Maleate instead of Zenzedi may experience undertreatment of their symptoms, leading to functional impairment and an increased risk of accidents or injury.
  • The recall comes amidst a national shortage of ADHD drugs, creating further confusion and unpredictability for people with ADHD who have struggled to find medications for their condition.
  • Consumers who have the recalled medication should return it to their pharmacy immediately and contact their health care provider if they have any bad reactions to the drug.
Hero image